Neurotech International Limited (ASX:NTI)
0.0140
-0.0010 (-6.67%)
Jun 22, 2026, 9:59 AM AEST
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 19.77 million as of June 18, 2026. Its market cap has decreased by -18.12% in one year.
Market Cap
19.77M
Enterprise Value
13.42M
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 19.77M, a decrease of -21.22%. That is a compound annual growth rate of -2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 19.77M | 8.91% |
| Dec 31, 2025 | 18.15M | -68.34% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Patrys | 30.00M |
| EZZ Life Science Holdings | 24.00M |
| Noxopharm | 22.43M |
| Algorae Pharmaceuticals | 21.24M |
| NeuroScientific Biopharmaceuticals | 20.62M |
| Opthea | 19.15M |
| Proteomics International Laboratories | 19.00M |
| Argenica Therapeutics | 14.13M |